Plasminogen activator inhibitor (PAI)-1 suppresses inhibition of gastric emptying by cholecystokinin (CCK) in mice

Regulatory Peptides

Volumn 185, Issue , 2013, Pages 9-13

  Gamble, Joanne ^a   Kenny, Susan ^a   Dockray, Graham J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

CCK; Gastric emptying; PAI 1

Indexed keywords

CHOLECYSTOKININ; GASTRIN; LORGLUMIDE; PEPTONE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; MEAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH EMPTYING; STOMACH PARIETAL CELL; TRANSGENIC MOUSE; WILD TYPE;

CCK; CHOLECYSTOKININ; G17; GASTRIC EMPTYING; GASTRIN; PAI; PAI-1; PLASMINOGEN ACTIVATOR INHIBITOR;

ANIMALS; CHOLECYSTOKININ; GASTRIC EMPTYING; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 84880294416     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2013.06.005     Document Type: Article

References (35)

1. Debas H.T., Farooq O., Grossman M.I. Inhibition of gastric emptying is a physiological action of cholecystokinin. Gastroenterology 1975, 68:1211-1217.
2. Raybould H.E., Tache Y. Cholecystokinin inhibits gastric motility and emptying via a capsaicin-sensitive vagal pathway in rats. Am J Physiol 1988, 255:G242-G246.
3. Forster E.R., Green T., Elliot M., Bremner A., Dockray G.J. Gastric emptying in rats: role of afferent neurons and cholecystokinin. Am J Physiol 1990, 258:G552-G556.
4. Fried M., Erlacher U., Schwizer W., Lochner C., Koerfer J., Beglinger C., Jansen J.B., Lamers C.B., Harder F., Bischof-Delaloye A. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide. Gastroenterology 1991, 101:503-511.
5. Meyer B.M., Werth B.A., Beglinger C., Hildebrand P., Jansen J.B., Zach D., Rovati L.C., Stalder G.A. Role of cholecystokinin in regulation of gastrointestinal motor functions. Lancet 1989, 2:12-15.
6. Dockray G.J. Cholecystokinin. Curr Opin Endocrinol Diabetes Obes 2012, 19:8-12.
7. Dockray G.J. The versatility of the vagus. Physiol Behav 2009, 97:531-536.
8. Barrachina M.D., Martinez V., Wang L., Wei J.Y., Tache Y. Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice. Proc Natl Acad Sci U S A 1997, 94:10455-10460.
9. Date Y., Toshinai K., Koda S., Miyazato M., Shimbara T., Tsuruta T., Niijima A., Kangawa K., Nakazato M. Peripheral interaction of ghrelin with cholecystokinin on feeding regulation. Endocrinology 2005, 146:3518-3525.
10. de Lartigue G., Lur G., Dimaline R., Varro A., Raybould H., Dockray G.J. EGR1 is a target for cooperative interactions between cholecystokinin and leptin, and inhibition by ghrelin, in vagal afferent neurons. Endocrinology 2010, 151:3589-3599.
11. Norsett K.G., Steele I., Duval C., Sammut S.J., Murugesan S.V., Kenny S., Rainbow L., Dimaline R., Dockray G.J., Pritchard D.M., Varro A. Gastrin stimulates expression of plasminogen activator inhibitor-1 in gastric epithelial cells. Am J Physiol Gastrointest Liver Physiol 2011, 301:G446-G453.
12. Kenny S., Duval C., Sammut S.J., Steele I., Pritchard D.M., Atherton J.C., Argent R.H., Dimaline R., Dockray G.J., Varro A. Increased expression of the urokinase plasminogen activator system by Helicobacter pylori in gastric epithelial cells. Am J Physiol Gastrointest Liver Physiol 2008, 295:G431-G441.
13. Keates A.C., Tummala S., Peek R.M., Csizmadia E., Kunzli B., Becker K., Correa P., Romero-Gallo J., Piazuelo M.B., Sheth S., Kelly C.P., Robson S.C., Keates S. Helicobacter pylori infection stimulates plasminogen activator inhibitor 1 production by gastric epithelial cells. Infect Immun 2008, 76:3992-3999.
14. Kenny S.H., Gamble J., Lyons S., Vlatkovic N., Dimaline R., Varro A., Dockray G.J. Gastric expression of plasminogen activator inhibitor (PAI)-1 is associated with hyperphagia and obesity in mice. Endocrinology 2013, 154:718-726.
15. Berkenpas M.B., Lawrence D.A., Ginsburg D. Molecular evolution of plasminogen activator inhibitor-1 functional stability. EMBO J 1995, 14:2969-2977.
16. Forster E.R., Dockray G.J. The role of cholecystokinin in inhibition of gastric emptying by peptone in the rat. Exp Physiol 1992, 77:693-699.
17. Green T., Dimaline R., Peikin S., Dockray G.J. Action of the cholecystokinin antagonist L364,718 on gastric emptying in the rat. Am J Physiol 1988, 255:G685-G689.
18. Landin K., Stigendal L., Eriksson E., Krotkiewski M., Risberg B., Tengborn L., Smith U. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 1990, 39:1044-1048.
19. Boehm J.R., Kutz S.M., Sage E.H., Staiano-Coico L., Higgins P.J. Growth state-dependent regulation of plasminogen activator inhibitor type-1 gene expression during epithelial cell stimulation by serum and transforming growth factor-beta1. J Cell Physiol 1999, 181:96-106.
20. Dellas C., Loskutoff D.J. Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease. Thromb Haemost 2005, 93:631-640.
21. Little T.J., Horowitz M., Feinle-Bisset C. Modulation by high-fat diets of gastrointestinal function and hormones associated with the regulation of energy intake: implications for the pathophysiology of obesity. Am J Clin Nutr 2007, 86:531-541.
22. Covasa M. Deficits in gastrointestinal responses controlling food intake and body weight. Am J Physiol Regul Integr Comp Physiol 2010, 299:R1423-R1439.
23. Kentish S., Li H., Philp L.K., O'Donnell T.A., Isaacs N.J., Young R.L., Wittert G.A., Blackshaw L.A., Page A.J. Diet-induced adaptation of vagal afferent function. J Physiol 2012, 590:209-221.
24. de Lartigue G., Barbier dlS, Espero E., Lee J., Raybould H.E. Diet-induced obesity leads to the development of leptin resistance in vagal afferent neurons. Am J Physiol Endocrinol Metab 2011, 310:E187-E195.
25. Raybould H.E. Gut microbiota, epithelial function and derangements in obesity. J Physiol 2012, 590:441-446.
26. Dockray G.J., Burdyga G. Plasticity in vagal afferent neurones during feeding and fasting: mechanisms and significance. Acta Physiol (Oxf) 2011, 201:313-321.
27. Daly D.M., Park S.J., Valinsky W.C., Beyak M.J. Impaired intestinal afferent nerve satiety signalling and vagal afferent excitability in diet induced obesity in the mouse. J Physiol 2011, 589:2857-2870.
28. Alessi M.C., Poggi M., Juhan-Vague I. Plasminogen activator inhibitor-1, adipose tissue and insulin resistance. Curr Opin Lipidol 2007, 18:240-245.
29. Okano-Matsumoto S., McRoberts J.A., Tache Y., Adelson D.W. Electrophysiological evidence for distinct vagal pathways mediating CCK-evoked motor effects in the proximal versus distal stomach. J Physiol 2011, 589:371-393.
30. Dockray G.J. Cholecystokinin and gut-brain signalling. Regul Pept 2009, 155:6-10.
31. Abderrahmani R., Francois A., Buard V., Tarlet G., Blirando K., Hneino M., Vaurijoux A., Benderitter M., Sabourin J.C., Milliat F. PAI-1-dependent endothelial cell death determines severity of radiation-induced intestinal injury. PLoS One 2012, 7:e35740.
32. Hyland N.P., Chambers A.P., Keenan C.M., Pittman Q.J., Sharkey K.A. Differential adipokine response in genetically predisposed lean and obese rats during inflammation: a role in modulating experimental colitis?. Am J Physiol Gastrointest Liver Physiol 2009, 297:G869-G877.
33. Laerum O.D., Illemann M., Skarstein A., Helgeland L., Ovrebo K., Dano K., Nielsen B.S. Crohn's disease but not chronic ulcerative colitis induces the expression of PAI-1 in enteric neurons. Am J Gastroenterol 2008, 103:2350-2358.
34. Kurosawa M., Uvnas-Moberg K., Miyasaka K., Lundeberg T. Interleukin-1 increases activity of the gastric vagal afferent nerve partly via stimulation of type A CCK receptor in anesthetized rats. J Auton Nerv Syst 1997, 62:72-78.
35. Bucinskaite V., Kurosawa M., Miyasaka K., Funakoshi A., Lundeberg T. Interleukin-1beta sensitizes the response of the gastric vagal afferent to cholecystokinin in rat. Neurosci Lett 1997, 229:33-36.